Correct Capital Wealth Management’s AbbVie ABBV Stock Holding History

Correct Capital Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.03M	Sell	9,330 -31	-0.3%	-$6.88K	0.38%	36
2025 Q4	$2.14M	Buy	9,361 +489	+6%	+$111K	0.4%	35
2025 Q3	$2.05M	Buy	8,872 +222	+3%	+$45.2K	0.34%	38
2025 Q2	$1.61M	Buy	8,650 +351	+4%	+$65.2K	0.23%	42
2025 Q1	$1.74M	Buy	8,299 +227	+3%	+$44.1K	0.28%	36
2024 Q4	$1.43M	Buy	8,072 +703	+10%	+$129K	0.29%	38
2024 Q3	$1.46M	Buy	7,369 +1,295	+21%	+$242K	0.32%	39
2024 Q2	$1.04M	Buy	6,074 +663	+12%	+$110K	0.24%	49
2024 Q1	$985K	Buy	5,411 +682	+14%	+$118K	0.23%	55
2023 Q4	$733K	Buy	+4,729	New	+$689K	0.19%	61

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Correct Capital Wealth Management's ABBV Position: Q1 2026 in Review

Correct Capital Wealth Management reduced its AbbVie (ABBV) stake by 0.33% in Q1 2026, selling an estimated $6.88K and leaving 9,330 shares worth $2.03M. The position accounts for 0.38% of the portfolio, ranked #36.

Correct Capital Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.14M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Correct Capital Wealth Management held 9,330 shares of AbbVie worth $2.03M as of Q1 2026.
Correct Capital Wealth Management sold 31 AbbVie shares in Q1 2026, an estimated $6.88K.
AbbVie made up 0.38% of Correct Capital Wealth Management's portfolio in Q1 2026, its #36 holding.
Correct Capital Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Correct Capital Wealth Management's AbbVie position peaked at $2.14M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Correct Capital Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.